MDWD

Mediwound

• PUBT·05/07 12:00

  MediWound to report first-quarter 2026 results, hosts conference call and webcast

• TipRanks·05/06 20:34

  MediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting

• TipRanks·04/23 14:00

  MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market

• TipRanks·04/13 19:25

  MediWound: EscharEx Phase III Upside and NexoBrid Traction Support Compelling Buy Thesis

• TipRanks·04/09 17:30

  Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)

• Benzinga·04/07 11:03

  MediWound Showcases New Wound Healing Data Across 3 Global Conferences, EscharEx Study Results Back Late-Stage Trials And Expansion Into Diabetic Ulcers

• Reuters·04/07 11:01

  MediWound presents new EscharEx data backing Phase III VALUE trial in venous leg ulcers

• TipRanks·04/06 14:10

  Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Mediwound (MDWD)

• TipRanks·04/02 21:21

  MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid

• TipRanks·04/02 19:37

  MediWound says Vericel awarded ten-year contract valued at up to $197M

• Reuters·04/02 19:26

  MediWound says Vericel wins BARDA contract for NexoBrid worth up to $197 million

• TipRanks·03/30 22:40

  MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus

• Reuters·03/30 21:32

  MediWound announces annual shareholder meeting, issues proxy statement and voting materials

• Reuters·03/25 11:20

  MediWound files Form 3 initial beneficial ownership statement; director Vickie Rae Driver reports 1,910 ordinary shares

• Reuters·03/18 21:35

  MediWound Ltd. files Form 3 initial beneficial ownership statement for CFO Hana Luxenburg Kalfon